Company Filing History:
Years Active: 2014-2016
Title: Innovations of William E. Sweeney
Introduction
William E. Sweeney is a notable inventor based in Waukesha, WI (US). He has made significant contributions to the field of medical research, particularly in the area of polycystic kidney and liver diseases. With a total of 2 patents, his work focuses on innovative methods to address critical health issues.
Latest Patents
Sweeney's latest patents include methods for modulating cell proliferation and cyst formation in polycystic kidney and liver diseases. The first patent provides a method for preferentially reducing the proliferation of cystic epithelial cells in the kidney or bile duct in a mammal. This is achieved by administering a 20-HETE synthesizing enzyme inhibitor or a 20-HETE antagonist in an amount sufficient to preferentially reduce the proliferation of cystic epithelial cells over normal epithelial cells. Additionally, this invention aims to prevent or treat conditions such as autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polycystic kidney disease (ARPKD) through similar administration methods.
Career Highlights
William E. Sweeney is affiliated with the Medical College of Wisconsin, Inc., where he continues to advance his research and innovations. His work has the potential to significantly impact the treatment of polycystic kidney and liver diseases, providing new avenues for patient care.
Collaborations
Sweeney has collaborated with esteemed colleagues such as Ellis D. Avner and Richard J. Roman, contributing to a rich environment of research and innovation.
Conclusion
William E. Sweeney's contributions to medical research through his patents highlight the importance of innovation in addressing complex health challenges. His work continues to pave the way for advancements in the treatment of polycystic kidney and liver diseases.